Phase I/II study of carboplatin with weekly ifostamide and docetaxel in recurrent or metastatic head and neck squamous cell cancers (HN-SCC).

被引：0
|
作者：
Chauhan, B [1 ]
Wanebo, H [1 ]
Rathore, R [1 ]
Chougule, P [1 ]
Kennedy, T [1 ]
Ready, N [1 ]
机构：
[1] Brown Univ, Oncol Grp, Providence, RI 02912 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5601
引用
收藏
页码：513S / 513S
页数：1
相关论文
共 50 条
  • [21] Phase I/II study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma
    Tada, Yuichiro
    Maruya, Shin-Ichiro
    Saotome, Takashi
    Miura, Kouki
    Masubuchi, Tatsuo
    Fushimi, Chihiro
    Okamoto, Isaku
    Takeishi, Etsuro
    Yamada, Shuhei
    Asai, Hiroaki
    Kamata, Shin-Etsu
    ONCOLOGY LETTERS, 2012, 4 (05) : 898 - 904
  • [22] Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
    Cho, Byoung Chul
    Keum, Ki Chang
    Shin, Sang Joon
    Choi, Hye Jin
    Lee, Young Joo
    Kim, Se Hun
    Choi, Eun Chang
    Kim, Joo Hang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 27 - 32
  • [23] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Tang, Patricia A.
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Pond, Gregory R.
    Johnson, Caitlin
    Colevas, A. Dimitrios
    Synold, Timothy W.
    Vasist, Lakshmi S.
    Winquist, Eric
    INVESTIGATIONAL NEW DRUGS, 2008, 26 (03) : 257 - 264
  • [24] Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Kim, Moon Jin
    Kim, Sung Min
    Jung, Hyun Ae
    Hong, Jung Yong
    Chang, Won Jin
    Choi, Moon Ki
    Kim, Hye Soak
    Sun, Jong-Mu
    Park, Keunchil
    Ahn, Myung-Ju
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (05): : 1107 - 1115
  • [25] Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
    Byoung Chul Cho
    Ki Chang Keum
    Sang Joon Shin
    Hye Jin Choi
    Young Joo Lee
    Se Hun Kim
    Eun Chang Choi
    Joo Hang Kim
    Cancer Chemotherapy and Pharmacology, 2009, 65 : 27 - 32
  • [26] A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    de Souza, Jonas A.
    Davis, Darren W.
    Zhang, Yujian
    Khattri, Arun
    Seiwert, Tanguy Y.
    Aktolga, Serdal
    Wong, Stuart J.
    Kozloff, Mark F.
    Nattam, Sreenivasa
    Lingen, Mark W.
    Kunnavakkam, Rangesh
    Stenson, Kerstin M.
    Blair, Elizabeth A.
    Bozeman, Jeffrey
    Dancey, Janet E.
    Vokes, Everett E.
    Cohen, Ezra E. W.
    CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2336 - 2343
  • [27] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Patricia A. Tang
    Lillian L. Siu
    Eric X. Chen
    Sebastien J. Hotte
    Stephen Chia
    James K. Schwarz
    Gregory R. Pond
    Caitlin Johnson
    A. Dimitrios Colevas
    Timothy W. Synold
    Lakshmi S. Vasist
    Eric Winquist
    Investigational New Drugs, 2008, 26 : 257 - 264
  • [28] Decreased distant recurrence and preserved local control using dose dense induction weekly paclitaxel (P) and carboplatin (C) followed by concurrent paclitaxel, carboplatin and radiotherapy (CRT) in locally advanced head and neck squamous cell cancers (HN-SCC).
    Nadeem, A
    Desai, S
    Chougule, P
    Wanebo, H
    Ruhl, C
    Joyce, D
    Tarro, J
    Kennedy, T
    Ready, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 499S - 499S
  • [29] A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer
    Ferrari, Daris
    Fiore, Jessica
    Codeca, Carla
    Di Maria, Giuseppe
    Bozzoni, Samuela
    Bordin, Veronica
    Caldiera, Sarah
    Luciani, Andrea
    Zonato, Sabrina
    Floriani, Irene
    Foa, Paolo
    ANTI-CANCER DRUGS, 2009, 20 (03) : 185 - 190
  • [30] Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: A phase II study
    Fountzilas, G
    Athanassiadis, A
    Samantas, E
    Skarlos, D
    KalogeraFountzila, A
    Nikolaou, A
    Bacoyiannis, H
    Stathopoulos, G
    Kosmidis, P
    Daniilidis, J
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S65 - S67
12345